Annals of Oncology Advance Access originally published online on September 15, 2005
Annals of Oncology 2006 17(2):349-350; doi:10.1093/annonc/mdj036
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
letter to the editor |
Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
| The first 10% of the full text of this article appears below. |
We read with interest the article by Pico et al. [1
]. In their report, it was stated that a single cycle of high-dose chemotherapy (HDT) after three cycles of standard dose chemotherapy had no effect on treatment outcomes of patients with advanced germ-cell tumor failing first-line platinum chemotherapy compared with four cycles of standard dose
1 Department of Medical Oncology, Faculty of Medicine, Yeditepe University, Icerenkoy Mah, Devletyolu, Ankara Cad. 102104, Kozyatagi, Istanbul
* (E-mail: basakou@yahoo.com)